SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-031414
Filing Date
2014-05-15
Accepted
2014-05-15 17:11:23
Documents
13
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v377229_10q.htm 10-Q 371252
2 EXHIBIT 10.40 v377229_ex10-40.htm EX-10.40 75085
3 EXHIBIT 10.41 v377229_ex10-41.htm EX-10.41 75086
4 EXHIBIT 10.42 v377229_ex10-42.htm EX-10.42 86762
5 EXHIBIT 10.43 v377229_ex10-43.htm EX-10.43 64684
6 EXHIBIT 31.1 v377229_ex31-1.htm EX-31.1 10493
7 EXHIBIT 32.1 v377229_ex32-1.htm EX-32.1 4492
  Complete submission text file 0001144204-14-031414.txt   4628308

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT nwbo-20140331.xml EX-101.INS 538269
9 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20140331.xsd EX-101.SCH 68800
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20140331_cal.xml EX-101.CAL 43800
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20140331_def.xml EX-101.DEF 296612
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20140331_lab.xml EX-101.LAB 368194
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20140331_pre.xml EX-101.PRE 335079
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 14848775
SIC: 2834 Pharmaceutical Preparations